Literature DB >> 24488147

The reciprocal interactions between astrocytes and prostate cancer cells represent an early event associated with brain metastasis.

Eliane Gouvêa de Oliveira Barros1, Antonio Palumbo1, Pedro Lucas Prado Mello1, Rômulo Medina de Mattos1, Julianna Henriques da Silva1, Bruno Pontes1,2, Nathan Bessa Viana2,3, Rackele Ferreira do Amaral1, Flavia Regina Souza Lima1, Nathalia Meireles da Costa4, Celia Yelimar Palmero1, Leandro Miranda-Alves1, Christina Maeda Takiya5, Luiz Eurico Nasciutti6.   

Abstract

Tumor establishment, growth, and survival are supported by interactions with microenvironment components. Here, we investigated whether the interactions between prostate cancer cells and cortical astrocytes are associated to a potential role for astrocytes in tumor establishment. We demonstrate that astrocytes interact in vitro with prostatic cancers cells derived from different metastatic sites. Astrocytes and their secreted extracellular matrix, stimulate DU145 cell (a brain-derived prostate tumor cell line) proliferation while inhibiting cell death and modulating the expression of several genes related to prostate cancer progression, suggesting the activation of EMT process in these cells. In contrast, DU145 cells and their conditioned medium inhibited cell proliferation and induced cell death of astrocytes. On the other hand, the astrocytes were unable to significantly induce an increment of LNCaP cell (a lymph node-derived prostate tumor cell line) proliferative activity. In addition, LNCaP cells were also unable to induce cell death of astrocytes. Thus, we believe that DU145 cells, but not LNCaP cells, present an even more aggressive behavior when interacting with astrocytes. These results provide an important contribution to the elucidation of the cellular mechanisms involved in the brain microenvironment colonization.

Entities:  

Keywords:  Astrocytes; Brain metastasis; DU145 cells; Epithelial mesenchymal transition; LNCaP cells; Prostate cancer; TGFβ

Mesh:

Substances:

Year:  2014        PMID: 24488147     DOI: 10.1007/s10585-014-9640-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  35 in total

Review 1.  The ins and outs of the epithelial to mesenchymal transition in health and disease.

Authors:  M Angela Nieto
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-08       Impact factor: 13.827

Review 2.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

Review 3.  Adhesion molecule expression and regulation on cells of the central nervous system.

Authors:  S J Lee; E N Benveniste
Journal:  J Neuroimmunol       Date:  1999-08-03       Impact factor: 3.478

4.  Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.

Authors:  K Nabeshima; T Inoue; Y Shimao; Y Okada; Y Itoh; M Seiki; M Koono
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

5.  Brain metastases: a rare initial presentation of prostate cancer.

Authors:  Tal Grenader; Linda Shavit; Alexander Lossos; Galina Pizov; Mark Wygoda
Journal:  Int Urol Nephrol       Date:  2007-02-17       Impact factor: 2.370

6.  Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.

Authors:  S Eklöv; K Funa; H Nordgren; A Olofsson; T Kanzaki; K Miyazono; S Nilsson
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

7.  Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

Authors:  Mingfang Ao; Omar E Franco; Dean Park; Dayanidhi Raman; Karin Williams; Simon W Hayward
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Transforming growth factor-beta receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate?

Authors:  Nima Sharifi; Robert J Lechleider; William L Farrar
Journal:  J Mol Endocrinol       Date:  2007-11       Impact factor: 5.098

9.  Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma.

Authors:  Shona H Lang; Catherine Hyde; Ian N Reid; Ian S Hitchcock; Claire A Hart; A A Gordon Bryden; Jean-Marie Villette; Michael J Stower; Norman J Maitland
Journal:  Prostate       Date:  2002-09-01       Impact factor: 4.104

10.  Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.

Authors:  Pin-Shern Chen; Yuan-Wei Shih; Hsiang-Ching Huang; Hsing-Wen Cheng
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

View more
  10 in total

Review 1.  Advances in decoding breast cancer brain metastasis.

Authors:  Chenyu Zhang; Dihua Yu
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

Review 2.  Malignant invasion of the central nervous system: the hidden face of a poorly understood outcome of prostate cancer.

Authors:  Eliane Gouvêa de Oliveira Barros; Nathalia Meireles Da Costa; Celia Yelimar Palmero; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti; Antonio Palumbo
Journal:  World J Urol       Date:  2018-07-06       Impact factor: 4.226

3.  Mangiferin inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 expression and cellular invasion by suppressing nuclear factor-κB activity.

Authors:  Matharage Gayani Dilshara; Chang-Hee Kang; Yung Hyun Choi; Gi-Young Kim
Journal:  BMB Rep       Date:  2015-10       Impact factor: 4.778

4.  Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.

Authors:  Qinlong Li; Lijuan Yin; Lawrence W Jones; Gina C-Y Chu; Jason B-Y Wu; Jen-Ming Huang; Quanlin Li; Sungyong You; Jayoung Kim; Yi-Tsung Lu; Stefan Mrdenovic; Ruoxiang Wang; Michael R Freeman; Isla Garraway; Michael S Lewis; Leland W K Chung; Haiyen E Zhau
Journal:  Oncotarget       Date:  2016-12-20

5.  ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.

Authors:  Anwen Wei; Bo Fan; Yujie Zhao; Han Zhang; Liping Wang; Xiao Yu; Qingmin Yuan; Deyong Yang; Shujing Wang
Journal:  Oncotarget       Date:  2016-10-04

6.  Expression and significance of PTEN and Claudin-3 in prostate cancer.

Authors:  Xinglong Ye; Lijing Zhao; Jing Kang
Journal:  Oncol Lett       Date:  2019-04-03       Impact factor: 2.967

Review 7.  Genetic instability in the tumor microenvironment: a new look at an old neighbor.

Authors:  Antonio Palumbo; Nathalia de Oliveira Meireles Da Costa; Martin Hernan Bonamino; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Mol Cancer       Date:  2015-07-31       Impact factor: 27.401

8.  An Integrative Platform for Three-dimensional Quantitative Analysis of Spatially Heterogeneous Metastasis Landscapes.

Authors:  Ian H Guldner; Lin Yang; Kyle R Cowdrick; Qingfei Wang; Wendy V Alvarez Barrios; Victoria R Zellmer; Yizhe Zhang; Misha Host; Fang Liu; Danny Z Chen; Siyuan Zhang
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

Review 9.  Factors involved in cancer metastasis: a better understanding to "seed and soil" hypothesis.

Authors:  Qiang Liu; Hongfei Zhang; Xiaoli Jiang; Caiyun Qian; Zhuoqi Liu; Daya Luo
Journal:  Mol Cancer       Date:  2017-12-02       Impact factor: 27.401

Review 10.  [Tumor Cells and Micro-environment in Brain Metastases].

Authors:  Wen Zhong; Chengping Hu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.